Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis

NCT01535027 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: teriparatide
DRUG: teriparatide and raloxifene
DRUG: teriparatide and alendronate

Sponsor

Medical University of Vienna